Abstract:Objectives The aims of this study were to analyze the clinical characteristics of patients with recurrent and metastatic sinonasal undifferentiated carcinoma (SNUC) and evaluate the current treatment strategies to help guide future management. Design This is a retrospective cohort study. Setting The study was conducted at six international tertiary treatment centers. Participants Patients with documented diagnoses of recurrent or metastatic SNUC since 1983 were included in the study. Main Outcome Measures Patient demographics and clinical characteristics were collected. Primary outcome measures included disease-specific survival (DSS), overall survival (OS), and time to recurrence (TTR) following initial treatment. Further univariable and multivariable analyses were performed to assess for prognostic factors. Results A total of 97 patients with a mean (standard deviation [SD]) age of 52.4 (15.6) were identified, 15 of whom presented with metastatic SNUC and 90 of whom developed recurrence. Management in both populations was widely variable. For patients with metastatic disease, the 1-year DSS probability was 33.3% (95% confidence interval [CI], 10.8–100%). For patients with recurrent SNUC, the 1- and 5-year DSS probabilities were 45.7% (95% CI, 31.9–65.6%) and 8.6% (95% CI, 2.9–25.3%), respectively. The median (interquartile range [IQR]) TTR was 8 months (3–18.5 months). Multivariable analyses revealed a significant association between orbital involvement on initial presentation and TTR (hazard ratio [HR] = 3.28; 95% CI, 1.45–7.42; p = 0.004). Conclusions To our knowledge, this is the first study addressing metastatic and recurrent SNUC based on a large patient cohort. Orbital extension of the primary SNUC may predict a higher probability of recurrence following treatment, suggesting the possible utility of a more aggressive treatment in this subgroup of patients. A heterogenous patient population and wide variability in management emphasize the challenges in standardizing care; however, dismal survival rates demonstrate the necessity for further evaluation of current approaches to improve evidence-based recommendations. This study was presented at the North American Skull Base Society Annual meeting on February 18, 2024, in Atlanta, Georgia. * These authors contributed equally to this work. † These authors contributed equally to this work and are co-corresponding authors. Received: 16 June 2024 Accepted: 03 September 2024 Article published online: 03 October 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

SNOT‐22 subdomain outcomes following treatment for sinonasal malignancy: A prospective, multicenter study

Predictive factors for decreased baseline quality of life in patients with sinonasal malignancies

University of Washington Quality of Life subdomain outcomes after treatment of sinonasal malignancy: A prospective, multicenter study

International, Multi-Institutional Evaluation of Practice Patterns and Outcomes for Recurrent and Metastatic Sinonasal Undifferentiated Carcinoma

Evaluation of sinonasal-related quality of life of 49 patients undergoing endoscopic skull base surgery

Quality-of-Life Outcomes Following Endoscopic Resection of Sinonasal Inverted Papilloma

Outcome for sinonasal malignancies: a population-based survey

Predictors of Sinonasal Improvement After Highly Effective Modulator Therapy in Adults with Cystic Fibrosis

SNOT-22-based clusters in chronic rhinosinusitis without nasal polyposis exhibit distinct endotypic and prognostic differences

Quality of Life Survey on Patients with Chronic Rhinosinusitis by Using Chinese Version of the 22-Item Sinonasal Outcome Test(snot-22)

Olfactory-specific quality of life outcomes after endoscopic sinus surgery

Screening for Psychiatric Disorders in Chronic Rhinosinusitis Patients Waiting for Surgery: A Prospective Cross‐Sectional Study

Clinical and 22-item Sino-Nasal Outcome Test symptom patterns in primary headache disorder patients presenting to otolaryngologists with "sinus" headaches, pain or pressure

Postinfectious conditions challenge disease-specificity of SNOT-22

Treatment and related morbidity of nasal cavity and paranasal sinus cancers

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

Quality of Life Following Salvage Endoscopic Nasopharyngectomy in Patients with Recurrent Nasopharyngeal Carcinoma: A Prospective Study

Prognostic Indicators for Salvage Surgery of Recurrent Sinonasal Malignancy

Assessment of surgical results in patients with empty nose syndrome using the 25-item Sino-Nasal Outcome Test Evaluation.

Quality‐of‐life and olfaction changes observed with short‐term medical management of chronic rhinosinusitis

A Clinical Study of Nasal Polyposis and Comparison of the Different Methods of its Management